Search results
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoAxsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript February 20, 2024 Axsome...
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Is Expected To Breakeven In The Near Future
Simply Wall St. via Yahoo Finance· 9 months agoAxsome Therapeutics, Inc. (NASDAQ:AXSM) is possibly approaching a major achievement in its business,...
As Axsome Therapeutics, Inc. (NASDAQ:AXSM) hits US$2.1b market cap, insiders may be dismayed about...
Simply Wall St. via Yahoo Finance· 2 years agoLast week, Axsome Therapeutics, Inc. (NASDAQ:AXSM) insiders, who had purchased shares in the...
Analysts Are Updating Their Axsome Therapeutics, Inc. (NASDAQ:AXSM) Estimates After Its...
Simply Wall St. via Yahoo Finance· 2 years agoShareholders of Axsome Therapeutics, Inc. (NASDAQ:AXSM) will be pleased this week, given that the...
Axsome (AXSM) Q3 Loss Narrower Than Expected, Revenues Miss
Zacks via Yahoo Finance· 2 years agoAxsome Therapeutics, Inc. AXSM incurred a loss of $1.03 per share (excluding intangible asset...
Axsome Therapeutics Inc (AXSM) Reports 244% YoY Growth in 3Q 2023 Product Revenue
GuruFocus.com via Yahoo Finance· 6 months agoAxsome Therapeutics Inc (NASDAQ:AXSM) reports a 244% year-over-year growth in total product revenue for 3Q 2023, amounting to $57.8 million. Auvelity 3Q 2023 net product sales grew by 36% quarter-over-quarter ...
Is Axsome Therapeutics Stock a Buy Now?
Motley Fool· 2 years agoAxsome Therapeutics (NASDAQ: AXSM) has had a transformative past 10 months. With that said, let's see what the future may hold for Axsome Therapeutics....
Q1 2024 Axsome Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 week agoParticipants Darren Opland; Director, Corporate Communications; Axsome Therapeutics Inc Herriot Tabuteau; Chairman of the Board, President, Chief Executive Officer, Founder; Axsome Therapeutics ...
If You Invested $5,000 in Axsome Therapeutics in 2019, This Is How Much You Would Have Today
Motley Fool· 2 years agoAxsome Therapeutics (NASDAQ: AXSM) has been making headlines for two reasons this year. Back in...
Axsome's New Drug Is Scoring a Win. Is the Stock a Buy?
Motley Fool· 1 year agoAxsome Therapeutics (NASDAQ: AXSM) stood out last year. The biotech began selling its first two...
